Publications

Machine Learning-Derived Predictive Risk Score for Prediabetes and Type 2 Diabetes Development in Parous Women

Diabetes Metab Syndr Obes.
Taschereau A, Wong J, Harnois-Leblanc S, Brunet MA, Doyon M, Arguin M, Rifas-Shiman SL, Oken E, Perron P, Jacques PÉ, Bouchard L, Hivert MF.

Health Care Costs and Use of Patients Prescribed Four Different Obesity Medications

Obesity
Lewis, Kristina H.; Zhang, Fang; LeCates, Robert F.; Argetsinger, Stephanie; Albert, Stefanie; Iyer, Geetha S.; Connolly, John G.; Wharam, James F.; Arterburn, David E.; Ross‐Degnan, Dennis; Toh, Sengwee

Personal Utility in Healthcare System Decision-Making: Addressing Ethical Tensions Through Fit-for-Purpose Measurement Approaches

Am J Bioeth.
Smith HS.

Visual Outcomes of Plasma Exchange for Acute Optic Neuritis: A Report by the American Academy of Ophthalmology.

Ophthalmology
Chen JJ, Oke I, Dinkin MJ, El-Dairi MA, Gaier ED, Gilbert AL, MacIntosh PW, Moss HE, Pineles SL, Heidary G.

Rethinking How We Provide Guidance When Evidence is Limited

Clin Infect Dis
Mohajer MA, Klompas M, Al-Hasan M, Colgrove R, Doron S, File T, Pettit NN, Pulia M, Weissman S.

Risk of Fetal Exposure to Teratogenic Medications: Development of Evidence for the Teratogenic Risk Impact and Mitigation (TRIM) Tool

Drug Saf.
Wang Y, Ewig CLY, Smolinski NE, Toyserkani GA, LaCivita C, Zhou EH, Dal Pan GJ, Thai TN, Maro JC, Rasmussen SA, Winterstein AG.

Selective Digestive Decontamination - Finding the Way Forward

N Engl J Med.
Klompas M.

Impact of Procalcitonin Testing on Antibiotic Use in Patients Hospitalized With Community-Acquired Pneumonia: A Multi-Hospital Cohort Study

Clin Infect Dis.
Deshpande A, Schulte R, Walker RE, Pallotta AM, Wang M, Kadri SS, Haessler S, Klompas M, Lindenauer PK, Rothberg MB.

Opportunities to improve open All of Us data to convey CYP2D6 pharmacological relevance and interpretation overall and according to ancestry

Front Pharmacol.
Hendricks-Sturrup RM, Christensen KD, Lu CY.

Persistent HIV Transmission Misconceptions Among People Who Inject Drugs in Massachusetts, USA

AIDS Behav.
Shaw LC, Jimenez YS, Sproesser DM, Hayes E, Baumgartner K, Krakower DS, Bordeu M, Mimiaga MJ, Bositis CM, Bazzi AR, Biello KB.

The power, potential of real-world data in randomized controlled trials: proceedings from a multistakeholder think tank

Trials.
Nouhravesh N, Jackman JG, Hernandez AF, Lee C, Hornik CP, Zacherle E, Waldstreicher J, Cocoros N, Brown S, Biering-Sorensen T, Chiswell K, Wruck L, James SK.

Ventilator-Associated Events: Surveillance and Prevention.

Infect Dis Clin North Am
Zanella MC, Rhee C, Klompas M.

An expedited chart review process for large database studies using natural language processing and multi-wave adaptive sampling

Epidemiology.
Wang SV, Hahn G, Kattinakere Sreedhara S, Mahesri M, Pillai HS, Aldis R, Lii J, Dutcher SK, Eniafe R, Jones JT, Kim K, He J, Lee H, Toh S, Desai RJ, Yang J.

HIV Preexposure Prophylaxis Uptake Among US Youth in a National Claims Database.

JAMA Pediatr
Venturelli N, Krakower D, Garabedian L

Cardiovascular health across childhood and adolescence and proteomic biomarkers in late adolescence.

Eur J Prev Cardiol
Lin Z, Rifas-Shiman SL, de Ferranti SD, Perng W, Hivert MF, Aris IM.

Long-read assembly reveals vast transcriptional complexity in the placenta associated with metabolic and endocrine function

Nat Commun.
Bresnahan ST, Yong HEJ, Nemani A, Wu WH, Lopez S, Chan JKY, White F, Jacques PÉ, Hivert MF, Chan SY, Love MI, Huang JY, Bhattacharya A.

Comment on: Glucagon-Like Peptide-1 Receptor Agonist Use and Risk of Cataract Development.

Am J Ophthalmol
Yu HN, Oke I, Oatts JT.

Trends in use of poly (ADP-ribose) polymerase inhibitor (PARPi) in ovarian cancer

Cancer Epidemiol.
Dottino JA, Baumann KE, Esselen KM, Costa R, Argetsinger S, Ross-Degnan D, Wagner AK.

Cardiovascular Conditions and Symptoms in Deaths Attributed to Acute Stimulant Toxicity

Circ Popul Health Outcomes.
Coffin PO, McMahan VM, Chang YG, Luna Marti X, Antolin Muñiz M, Chang JS, Knoll J, Rodda LN.

Post-authorization safety study to assess the risk of diabetic ketoacidosis among type 2 diabetes mellitus patients treated with ertugliflozin compared to patients treated with other antihyperglycaemic agents in a Medicare and Medicaid population.

Diabet Med
Rai A, Marshall J, Nandyala S, Her M, Agan AA, Huang TY, Rodriguez-Watson C, Clary A, Diessner B, Nolan MB, Djibo DA, DeVries A, Daniels K, Zhang X, Wang T, Gantz I, Shankar R, Zale MM, Ejelonu P, Frederich R, Masiukiewicz U, Toh S.